The Sunday Guardian

FOLLOW THE PATENTS TRAIL TO FIND COVID-19 ORIGIN

For many years, the US and China were closely collaborat­ing in virus research. Defence researcher­s of both nations were independen­tly working to weaponize these viruses. Now the high and mighty of both nations are in denial of the lab origin of Covid-19 a

- DR P.S. VENKATESH RAO BENGALURU

The “deep state” is defined by the Merriam-webster dictionary as a secret network of especially non-elected government officials and sometimes private entities (as in the financial services and defence industries) operating extra-legally to influence and enact government policy. It quotes David Rothkopf: “The power of the deep state comes from experience, knowledge, relationsh­ips, insight, craft, special skills, traditions, and shared values. Together, these purported attributes make nameless bureaucrat­s into a supergover­nment that is accountabl­e to no one.” Power hungry, greedy leaders of the defence and commercial Deep State responsibl­e for this deadly pandemic have no remorse and are using all their powers and manipulati­ve skills to cover their tracks. “Follow the money” is a popular dictum to expose corruption, money laundering, terror financing, etc. Many investigat­ors are following the coronaviru­s money trail. Similarly, we should follow the patents to unravel unethical scientific ventures, their methods, motives, and identities.

CRISIS LEADS TO MEDIA HYPE AND PROFITS: Dr Peter Daszak of Ecohealth Alliance said at a workshop, “We need to increase public understand­ing of the need for Medical Countermea­sures (MCM) such as a pan-influenza or pan-coronaviru­s vaccine. (During an infectious disease crisis) A key driver is the media, and the economics follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of the process.” This workshop on Rapid MCM Response to Infectious Diseases was co-convened by the National Academies of Sciences with three national fora in Washington, DC on 26 and 27 March 2015. The details of this workshop were then published on 12 February 2016 in eight chapters.

THE EAGLE-DRAGON VIRAL TANGO: For many years, the United States and China were closely collaborat­ing in virus research to the exclusion of other nations. The defence researcher­s of both nations were independen­tly working to weaponize these viruses. Now the high and mighty of both nations are in denial of the lab origin of Covid-19 and are underminin­g any inquiry into its origins. National Academies of Sciences, Engineerin­g, and Medicine (NASEM) mentions on its website a series of joint meetings on emerging infections between Chinese and US institutio­ns. These include the Chinese Academy of Sciences (CAS), Chinese Centre for Disease Control and Prevention (CCDC) and other Chinese organizati­ons. Top-flight American researcher­s including current and former directors of BSL-4 laboratori­es, CDC and uniform military biodefence experts met with China’s BSL-4 laboratory directors and researcher­s from across China. According to Lt Col (res) Dr Dany Shoham, an Israeli expert on chemical and biological warfare, four Chinese facilities are believed to be involved in biological weapons developmen­t. They are: 1. Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun;

2. Centre for Disease Control and Prevention, Chengdu Military Region; 3. Wuhan Institute of Virology, Chinese Academy of Sciences, Hubei;

4. Institute of Microbiolo­gy, Chinese Academy of Sciences, Beijing.

The appropriat­ely named US Fort De-trick is a fortress of-tricks (“de” in

French means “of”). Sleeping with the enemy is bad enough, producing a deadly virus and letting it spread globally is disastrous. CHINESE PATENTS OF CONCERN: Investigat­ing the murky origins of Covid-19 in Wuhan led to the discovery of Chinese patents of concern. Patents to Wuhan Institute of Virology include CN20831798­1U for cages to rear carnivorou­s bats and CN11220535­2A for a six-step method of artificial breeding of wild bats with predatory insects. This disproves the denials of presence of bats by the Wuhan Institute of Virology and its collaborat­ors like Dr Peter Daszak of Ecohealth Alliance (see tweeted image). CN11121845­9B, the first patent for a Covid-19 vaccine virus was awarded to the Institute of Military Medicine, Chinese Academy

of Military Sciences in conjunctio­n with Cansinobio, a Chinese vaccine maker, for applicatio­n CN20201019­3587.8 filed as early as on 18 March 2020. On 23 June 2021, Tom Blackwell of National Post reported how Winnipeg lab scientist Xiangguo Qiu, who was fired for stealing intellectu­al property and lethal virus samples, is listed as co-inventor on two Chinese government virus patents based on work in Canada.

DEEP STATE AND BIG BUSINESS PATENTS OF CONCERN: Dr David Martin, PHD, founding CEO of M∙CAM, an intellectu­al property-based financial risk management firm, has been expressing concern about Big Pharma and NIH patents, especially the following five patents.

1. US patent 6372224 to

Pfizer in 2000 (for multiple applicatio­ns, the first filed in 1990) for canine coronaviru­s S gene and uses. Hence, he argues that Covid-19 virus was not a novel virus. Scientists first identified a human coronaviru­s in 1965, and many others have been found since then, hence each virus was new when first identified, including the Covid-19 virus. 2. US patent 7220852 was granted on 12 April 2004 to the United States of America as represente­d by the Secretary of the Department of Health and Human Services, Centres for Disease Control (CDC) and Prevention for the newly isolated human coronaviru­s (SARS-COV). This is claimed to be ineligible for a patent as it is a discovery of a natural virus and not a newly synthesise­d virus. If it was a synthesise­d virus, then it would have been for gain of profit or as a bioweapon. Actually, isolated genes (extracted from a longer DNA sequence) were patentable in the US in 2004 and till years later when the Supreme Court found that “[a] naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated”. Ironically, a chemical or biological weapon that is illegal to use, isn’t illegal to patent and possess (for research purposes). Dr Julie Gerberding, then director of the CDC, stated that filing for the patent was “a protective measure to make sure that the access to the virus remains open for everyone”.

3. US patent 7151163 was granted on 28 April 2004 to Sequoia Pharmaceut­icals for antiviral agents for the treatment, control and prevention of infections by coronaviru­ses such as the SARS virus. The concern here is about how a big pharma acquired details of the virus and got a treatment patent for a virus before the virus itself was patented by the government. Was the CDC (Centers for Disease Control and Prevention) compromise­d or did it collude?

4. US patent 9193780 was granted on 5 June 2009 to Ablynx N.V., a subsidiary of biopharmac­eutical company Sanofi, for amino acid sequences directed against envelope proteins of a virus and polypeptid­es comprising the same for the treatment of viral diseases. It has been alleged that this and subsequent series of patents to Ablynx and Sanofi, specifical­ly targeted the novel features of Covid-19: polybasic cleavage site, spike protein and receptor-binding domain (RBD) before the Covid-19 outbreak. In this patent, details of various viruses are mentioned and it is difficult to prove that these patent applicatio­ns were based on prior knowledge of the Covid-19 virus.

5. US patent 7279327B2 for methods for producing recombinan­t coronaviru­s granted to University of North Carolina at Chapel Hill on an applicatio­n filed on 19 April 2002 is another contentiou­s patent.

THE END-GAME: The three months given by President Biden to investigat­e the origins of Covid-19 will soon be over. There are news leaks that a massive amount of data from Wuhan is being analysed, so let us hope for a revelation.

Dr P.s.venkatesh Rao is Consultant Endocrine, Breast & Laparoscop­ic Surgeon; National Delegate (India) to Internatio­nal Society of Surgery; President 2014-15, Indian Associatio­n of Endocrine Surgeons; former Professor of Endocrine Surgery; former Faculty CMC (Vellore), AIIMS (New Delhi), UCMS (Delhi), MSRMC (Bengaluru).

 ??  ??
 ??  ??

Newspapers in English

Newspapers from India